The development of a biosimilar product requires extensive characterization at many stages. At the functional level, pharmacologic activity should be evaluated by appropriate in vitro and/or in vivo assays. However, these potency assays can be expensive and time consuming.
This paper reviews the qualification of cell-based assays for functional comparability analysis that provide an attractive alternative to more expensive and time-consuming assays.
This paper reviews the qualification of cell-based assays for functional comparability analysis that provide an attractive alternative to more expensive and time-consuming assays.
Ground Floor, Hazel House, Millennium Park, Naas, Co. Kildare,
W91 PXP3,
Naas, County Kildare, Ireland